Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | NPY1R | P25929 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 2/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6724506 | 0.98 | TACR1 (0.38) | TACR1MEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL6724496 | 0.93 | MEN1 (0.38) | TACR1MEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL6724024 | 0.93 | PTGER1 (0.37) | TACR1MEN1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL3370037 | 0.90 | TACR1 (0.41) | TACR1MEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL6724005 | 0.87 | CHKA (0.39) | TACR1MEN1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL13826147 | 0.85 | TAAR1 (0.39) | TACR1MEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL6723824 | 0.85 | TAAR1 (0.39) | TACR1MEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL6723582 | 0.85 | CHKA (0.41) | TACR1MEN1KMT2ASMN1; SMN2HTR7 | |
| SCHEMBL6723970 | 0.85 | TAAR1 (0.39) | TACR1MEN1KMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL6723985 | 0.85 | TAAR1 (0.39) | TACR1MEN1KMT2ASMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9735371-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2017-08-15 | — | — | US | disclosed |
| US-9735371-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2017-08-15 | — | — | US | disclosed |
| US-20170179399-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-06-22 | — | — | US | disclosed |
| US-20170179399-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-06-22 | — | — | US | disclosed |
| EP-2699641-B1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-05-17 | — | — | EP | disclosed |
| US-20140231715-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) | 2014-08-21 | — | — | US | disclosed |
| US-20140231715-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) | 2014-08-21 | — | — | US | disclosed |
| WO-2012143079-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-10-26 | — | — | WO | disclosed |
| US-8178216-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178216-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20090072718-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-03-19 | — | — | US | disclosed |
| US-20090072718-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090072718-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative | CRY1, GRK1, CRY2 | TACR1 4232/4885MEN1 974/4885KMT2A 1322/4885 |
| US-20170179399-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | CYP2C19, CYP1B1, CYP2C9 | TACR1 567/4885MEN1 105/4885KMT2A 2113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.